Core Viewpoint - Wanbangde's stock price has shown significant volatility, with a year-to-date increase of 71.38% but a recent decline of 4.09% over the last five trading days [2] Group 1: Stock Performance - As of September 25, Wanbangde's stock price was 11.02 CNY per share, with a market capitalization of 6.741 billion CNY [1] - The stock has experienced a 17.36% increase over the past 20 days and a 57.65% increase over the past 60 days [2] - The company has appeared on the "龙虎榜" (top trading list) five times this year, with the most recent occurrence on August 27 [2] Group 2: Financial Performance - For the first half of 2025, Wanbangde reported revenue of 579 million CNY, a year-on-year decrease of 23.15%, and a net profit attributable to shareholders of 13.4635 million CNY, down 64.29% year-on-year [2] - The company's main business revenue composition includes 41.63% from medical devices, 24.69% from chemical raw materials and preparations, 19.61% from other goods, and 14.07% from traditional Chinese medicine [2] Group 3: Shareholder Information - As of June 30, the number of shareholders for Wanbangde was 39,300, an increase of 42.08% from the previous period, while the average circulating shares per person decreased by 30.25% to 14,085 shares [2] Group 4: Dividend Information - Since its A-share listing, Wanbangde has distributed a total of 613 million CNY in dividends, with 122 million CNY distributed over the past three years [3]
万邦德跌2.04%,成交额1.11亿元,主力资金净流入713.63万元